Galera Therapeutics, Inc. - GRTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 05, 2026 | President and CEO | D | D | 30,000.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | President and CEO | D | D | 975.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | — | D | D | 240.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | — | D | D | 480.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | — | C | D | 661.31 | 0.0 | 0.0 | 0.0 | View | |
| Aug 05, 2026 | — | D | D | 47,434.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | — | C | A | 661,309.0 | — | — | 9,486,852.0 | View | |
| Aug 05, 2026 | — | D | D | 240.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | — | D | D | 40.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | — | D | D | 11.0 | — | — | 0.0 | View | |
| Aug 05, 2026 | Chief Accounting Officer | D | D | 10,000.0 | — | — | 0.0 | View | |
| May 29, 2026 | — | C | D | 20,813.82 | — | — | 0.0 | View | |
| May 29, 2026 | — | C | A | 20,813,818.0 | — | — | 61,029,978.0 | View |